嘉实中证医疗指数发起式C(014603)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
7,272,353.41 |
-58,636,936.93 |
-75,423,332.12 |
-83,705,975.99 |
| 利息合计 |
7,589.60 |
147,456.06 |
134,100.23 |
689,055.82 |
| 其中：存款利息收入 |
7,589.60 |
31,774.12 |
18,418.29 |
56,228.55 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-16,575,218.96 |
-64,194,048.42 |
-36,447,876.17 |
-23,190,758.37 |
| 其中：股票投资收益 |
-18,823,940.25 |
-67,756,648.08 |
-38,673,098.30 |
-28,267,653.73 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
366.65 |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
2,248,354.64 |
3,562,599.66 |
2,225,222.13 |
5,076,895.36 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
23,764,092.05 |
4,999,415.79 |
-39,138,296.65 |
-61,325,957.62 |
| 其他收入 |
75,890.72 |
410,239.64 |
28,740.47 |
121,684.18 |
| 费用 |
1,063,162.48 |
2,289,319.46 |
1,179,495.49 |
2,840,832.90 |
| 管理人报酬 |
602,853.22 |
1,289,986.16 |
658,652.74 |
1,594,293.18 |
| 基金托管费 |
120,570.64 |
257,997.20 |
131,730.51 |
318,858.60 |
| 销售服务费 |
259,456.34 |
578,295.95 |
299,712.65 |
738,725.38 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
80,282.28 |
162,623.71 |
88,983.15 |
186,677.23 |
| 利润总额 |
6,209,190.93 |
-60,926,256.39 |
-76,602,827.61 |
-86,546,808.89 |
微信公众号
证券之星APP
基本资料
